Immunomodulators Market Hits USD 233.7 Billion By 2025: Grand View Research, Inc.
The
global immunomodulators market is expected to reach USD 233.7
billion by 2025, according to a new study by Grand View Research, Inc. The
market is anticipated to be predominantly driven by high R&D investments
employed by the prominent companies, resulting into the large-scale production
of new and therapeutically advanced drugs. This is believed to widen the influx
of drugs at an unprecedented rate into the immunomodulators market hence
providing highly efficacious treatment alternatives for numerous autoimmune and
inflammatory diseases.
In
addition, increasing drugs resistance is predicted to be responsible for
boosting the clinical urgency to develop potentially new generation
immunomodulators with targeted therapy mechanisms. The aforementioned factors
cumulatively are expected to present significant growth opportunities over the
forecast period.
Furthermore,burgeoning presence of the key players is expected to promote the awareness
levels pertaining to benefits of immunomodulators amongst the patients as well
as the physicians. This is further expected to widen the immunomodulators
industry growth potential during the forecast period.
In
addition, increasing adoption of monoclonal antibodies for a wide range of
indications, such as, multiple sclerosis, Crohn’s disease, rheumatoid
arthritis, and Non-Hodgkin’s Lymphoma, which is expected to boost
immunomodulators industry over the forecast period. The consistent number of
product approvals of highly significant monoclonal antibodies in autoimmune
diseases is predicted to be responsible for widening the scope of growth.
Browse full research report on Global Immunomodulators market: http://www.grandviewresearch.com/industry-analysis/immunomodulators-market
Further Key Findings
From the Study Suggest:
- Immunosuppressant held the largest share of the product
segment in 2015, owing to increasing number of transplantation procedures
and need to prevent organ rejection
- Antibodies held the dominant share of immunosuppressant in 2015, owing to extensive utilization in kidney, liver, heart, and lung transplants resulting in greater revenue generation
- Immunostimulants expected to grow lucratively as a
result of lower influx of immunostimulant generics for application in HIV,
cancer and multiple sclerosis
- In 2015, North America dominated the global
immunomodulators market owing to presence of wide number of established
pharmaceutical companies involved in extensive commercialization
- The prominent participants are undertaking research and
clinical collaborative strategies to yield new drugs and thereby to gain
competitive advantage
- For instance, in March 2015, Novartis AG entered into
research collaboration with Aduro Biotech. This was carried out to enhance
its next generation cancer immunotherapy product pipeline
Browse more reports of this category by Grand
View Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has
segmented the immunomodulators market on the basis of product, application, and
region:
- Global Product Outlook (Revenue, USD Billion, 2014
- 2025)
- Immunosuppressant
- Antibodies
- Calcineurin inhibitors
- Glucocorticoids
- Antimetabolites
- Others
- Immunostimulants
- Vaccines
- Antibodies
- Others
- Global Application Outlook (Revenue, USD Billion,
2014 - 2025)
- Oncology
- Respiratory
- HIV
- Others
- Regional Outlook (Revenue, USD Billion, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
Access press
release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-immunomodulators-market
About Grand View
Research
Grand View Research,
Inc. is a U.S. based market research and consulting company, registered in the
State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales
Specialist, USA
Grand View Research, Inc
For more information: www.grandviewresearch.com
Comments
Post a Comment